; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (85) Ethaboxam Heading 9902.07.08 is amended— (A) by amending the article description to read as follows: N-[Cyano(2-thienyl)methyl]-4-ethyl-2-(ethylamino)-1,3- thiazole-5-carboxamide (Ethaboxam) (CAS No. 162650–77–3) (provided for in subheading 2934.10.90) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (86) Propiconazole Heading 9902.07.16 is amended— (A) by amending the article description to read as follows: 1-[[2-(2,4-Dichlorophenyl)-4-propyl-1,3-dioxolan-2-yl]- methyl]-1H-1,2,4-triazole (Propiconazole) (CAS No. 60207–90–1) (provided for in subheading 2934.99.12) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (87) Etoxazole Heading 9902.07.35 is amended— (A) by amending the article description to read as follows: 2-(2,6-Difluorophenyl)-4-[2-ethoxy-4-(2-methyl-2-propanyl)phenyl]- 4,5-dihydro-1,3-oxazole (Etoxazole) (CAS No. 153233–91–1) (provided for in subheadling 2934.99.18) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (88) Flucarbazone-sodium Heading 9902.07.65 is amended— (A) by amending the article description to read as follows: Sodium [(3-methoxy-4-methyl-5-oxo-4,5-dihydro-1H-1,2,4- triazol-1-yl)carbonyl]{[2-(trifluorometh- oxy)phenyl]sulfonyl}azanide (Flucarbazone-sodium) (CAS No. 181274–17–9) (provided for in subheading 2935.90.75) ; and (B) by striking 12/31/2020 and inserting 12/31/2024 . (89) Imazosulfuron Heading 9902.07.71 is amended— (A) by amending the article description to read as follows: 2-Chloro-N-[(4,6-dimethoxy-2-pyrimidinyl)carba- moyl]imidazo[1,2-a]pyridine-3-sulfonamide (Imazosulfuron) (CAS No. 122548–33–8) (provided for in subheading 2935.90.75)